134 related articles for article (PubMed ID: 36457141)
21. Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis.
Wang QP; Cao XZ; Wang XD; Gu J; Wen LM; Mao LM; Shan PN; Tang AG
PLoS One; 2013; 8(1):e52553. PubMed ID: 23341901
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
[TBL] [Abstract][Full Text] [Related]
23. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
Porcel JM; Bielsa S; Morales-Rull JL; Civit C; Cao G; Light RW; Esquerda A
Respirology; 2013 Apr; 18(3):540-5. PubMed ID: 23278975
[TBL] [Abstract][Full Text] [Related]
24. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
deFilippi CR; Seliger SL; Maynard S; Christenson RH
Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
[TBL] [Abstract][Full Text] [Related]
26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
28. Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides.
Saenger AK; Rodriguez-Fraga O; Ler R; Ordonez-Llanos J; Jaffe AS; Goetze JP; Apple FS
Clin Chem; 2017 Jan; 63(1):351-358. PubMed ID: 28062628
[TBL] [Abstract][Full Text] [Related]
29. Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan Treatment.
Nougué H; Michel T; Picard F; Lassus J; Sadoune M; Laribi S; Cohen-Solal A; Logeart D; Launay JM; Vodovar N
Clin Chem; 2023 Apr; 69(4):350-362. PubMed ID: 36762414
[TBL] [Abstract][Full Text] [Related]
30. Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients.
Guo M; Luo J; Zhao J; Shang D; Lv Q; Zang P
Med Sci Monit; 2018 Dec; 24():8840-8848. PubMed ID: 30523241
[TBL] [Abstract][Full Text] [Related]
31. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
32. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
[TBL] [Abstract][Full Text] [Related]
33. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
34. Assays Specific for BNP1-32 and NT-proBNP Exhibit a Similar Performance to Two Widely Used Assays in the Diagnosis of Heart Failure.
Lewis LK; Raudsepp SD; Whitlow JC; Appleby S; Pemberton CJ; Yandle TG; Mark Richards A
Clin Chem; 2022 Oct; 68(10):1292-1301. PubMed ID: 35932191
[TBL] [Abstract][Full Text] [Related]
35. NT-ProBNP levels in saliva and its clinical relevance to heart failure.
Foo JY; Wan Y; Kostner K; Arivalagan A; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
PLoS One; 2012; 7(10):e48452. PubMed ID: 23119023
[TBL] [Abstract][Full Text] [Related]
36. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
[TBL] [Abstract][Full Text] [Related]
37. The differential diagnostic value of serum NT-proBNP in hospitalized patients of heart failure with pneumonia.
Yang S; Li L; Cao J; Yu H; Xu H
J Clin Lab Anal; 2015 Jan; 29(1):37-42. PubMed ID: 24687945
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.
Clerico A; Fontana M; Zyw L; Passino C; Emdin M
Clin Chem; 2007 May; 53(5):813-22. PubMed ID: 17384013
[TBL] [Abstract][Full Text] [Related]
40. Immunodetection of glycosylated NT-proBNP circulating in human blood.
Seferian KR; Tamm NN; Semenov AG; Tolstaya AA; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
Clin Chem; 2008 May; 54(5):866-73. PubMed ID: 18339697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
